The #INcUAB25 were last week. Great talks and company! @marcosblancor @G_vdWalt96 & Armin gave fantastic presentations (Günter won an award!), @IreneFernandezz got Best Poster, and Emma et al. (coordinated by @albert_qr78) were recognized with the Featured Article 2024. Congrats!

We are really excited that our work identifying a circuit behind epilepsy in mitochondrial disease has been accepted @jclinicalinvest !!! @INC_UAB @UABBarcelona Kudos to everyone involved from the team and our collaborators!

Hot from the press!!! Extended description to follow!!

Hoy comienza nuestro I Congreso #MitoSpain en #Madrid. Queremos agradecer a nuestros patrocinadores y colaboradores, sin ellos no sería posible @ucb_iberia @Nutricia_es @Fundacion_ONCE #Urbasolar @100%natural @Chiesi_es @FundacionACDM @GA1Familia @Asanol

It’s #Mitoweek, a week to raise awareness for #mitochondrialdisease. Perfect time to launch our new site https://t.co/3zykwFGsqd :) and show we’re working nonstop to find treatments💚 So busy finding cures, we had to ask AI to generate a pic for the post, with amazing results 😅

Parallel cell-type specific neurodegenerative pathways in mitochondrial disease por Melania González @albert_qr78 de @UniBarcelona #47congresoSEBBM

1/ 🥳 🔬 ¡Ya podéis conocer los proyectos seleccionados en la convocatoria CaixaResearch de Investigación en Salud 2025! 34 investigaciones transformadoras de España y Portugal que buscan sentar las bases de la salud del mañana. 👇 🧵 https://t.co/JYwQUoSNHZ

Congratulations to Dr. @albert_qr78 , whose project has been selected in the CaixaResearch Health Call 2025!

Beyond happy to announce that a project led by @albert_qr78 will be funded with a CaixaResearch Health Call 2025 grant @CaixaResearch @CaixaResearchCA 🍾🍾🍾

Albert was on TV yesterday, at the final ceremony of La Marató 2019, where researchers presented the results of all the funded projects. With some makeup on, @albert_qr78 talked about Leigh syndrome and the advancements achieved thanks to La Marató funding 💚

Acte del 26è retorn social de #LaMarató @som3cat dels projectes #malaltiesminoritaries de l’edició 2019. Acte emotiu i apassionant 😊. Felicitats projectes finançats, especialment als grups de @INC_UAB @UABBarcelona @albert_qr78 @QuintanaLab @JMLBlab

La Marató del 2019 va recaptar diners per investigar sobre malalties minoritàries. Entre els projectes escollits, hi havia els dels @JMLBlab i el @QuintanaLab que buscaven tractaments per la malaltia de Lesch-Nyhan i la síndrome de Leigh. Ahir es presentaven els resultats 📺🔬

So great to have Laura back!!! Great excuse to enjoy a good lunch with the lab!

Last Friday, we stepped away from the lab for our traditional calçotada—and it couldn’t have been better! It was a great chance to unwind, enjoy some amazing food, and spend quality time together beyond the pipettes and tubes. Looking forward to the next one!

1) The @QuintanaLab focuses on mitochondrial diseases, which are caused by defects in mitochondria, the energy-producing structures within cells. These disorders can affect multiple organs, leading to severe neurological and muscular problems.

Today is the #RareDiseaseDay At the Institute, different research groups are dedicated to understanding and treating rare diseases.

Celebrating Carnival at @INC_UAB🎉 Which singers can you recognize?

Del 4 al 6 de marzo se celebra #BWAW un evento que promueve la #igualdad de género y el liderazgo #inclusivo, nuestra compañera @pgonzrodriguez participa como ponente. ¿Te la vas a perder? #BWAW2025 organizado por @ConsorciZF

Great visit yesterday from @WakeForest students to our campus, hosted by Dr. @RoserNadal (@LabhumaUAB). They explored our molecular biology, microscopy, and histology facilities and had the chance to visit the Anderolab and the @quintanalab. It was a pleasure to meet them!

16 female researchers from the Institute have been recognized in the 2025 Ranking of Spanish Women Researchers by @CSIC, which highlights the top 10.000 female scientists based on metrics like the h index and citations The ranking here: https://t.co/hH6IVBongQ 🧵(1/3)